These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19305698)

  • 21. Financial Burden and Out-of-Pocket Expenditures for Mental Health Across Different Socioeconomic Groups: Results from HealthCare for Communities.
    Ringel JS; Sturm R
    J Ment Health Policy Econ; 2001 Sep; 4(3):141-150. PubMed ID: 11967474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using policy simulation to predict drug plan expenditure when planning reimbursement changes.
    Dormuth CR; Burnett S; Schneeweiss S
    Pharmacoeconomics; 2005; 23(10):1021-30. PubMed ID: 16235975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of changes in private health expenditure on New Zealand households.
    Hopkins S; Cumming J
    Health Policy; 2001 Dec; 58(3):215-29. PubMed ID: 11641000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Private expenditures on healthcare: determinants, patterns and progressivity aspects.
    Achdut L
    Isr J Health Policy Res; 2019 Dec; 8(1):87. PubMed ID: 31862016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health equity in Lebanon: a microeconomic analysis.
    Salti N; Chaaban J; Raad F
    Int J Equity Health; 2010 Apr; 9():11. PubMed ID: 20398278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Out-of-pocket payments for health care in Croatia: implications for equity.
    Mastilica M; Bozikov J
    Croat Med J; 1999 Jun; 40(2):152-9. PubMed ID: 10234056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equity in household spending on alcoholic beverages in South Africa: assessing changes between 1995 and 2011.
    Fontes Marx M; London L; Harker N; Ataguba JE
    Int J Equity Health; 2019 May; 18(1):78. PubMed ID: 31138225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes In The Equity Of US Health Care Financing In The Period 2005-16.
    Jacobs PD; Selden TM
    Health Aff (Millwood); 2019 Nov; 38(11):1791-1800. PubMed ID: 31618081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of reference-based pricing for histamine-2 receptor antagonists and restricted access for proton pump inhibitors in British Columbia.
    Marshall JK; Grootendorst PV; O'Brien BJ; Dolovich LR; Holbrook AM; Levy AR
    CMAJ; 2002 Jun; 166(13):1655-62. PubMed ID: 12126319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term care financing: lessons from France.
    Doty P; Nadash P; Racco N
    Milbank Q; 2015 Jun; 93(2):359-91. PubMed ID: 26044633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
    Hanley GE; Morgan S
    Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Financial protection from health spending in the Philippines: policies and progress.
    Bredenkamp C; Buisman LR
    Health Policy Plan; 2016 Sep; 31(7):919-27. PubMed ID: 27072948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease.
    Hennessy D; Sanmartin C; Ronksley P; Weaver R; Campbell D; Manns B; Tonelli M; Hemmelgarn B
    Health Rep; 2016 Jun; 27(6):3-8. PubMed ID: 27305075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower-income families pay a higher share of income toward national health care spending than higher-income families do.
    Ketsche P; Adams EK; Wallace S; Kannan VD; Kannan H
    Health Aff (Millwood); 2011 Sep; 30(9):1637-46. PubMed ID: 21900653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.
    Leung GM; Tin KY; Yeung GM; Leung ES; Tsui EL; Lam DW; Tsang CS; Fung AY; Lo SV
    Hong Kong Med J; 2008 Apr; 14 Suppl 2():2-23. PubMed ID: 18587162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Private health expenditure in Ireland: Assessing the affordability of private financing of health care.
    Johnston BM; Burke S; Barry S; Normand C; Ní Fhallúin M; Thomas S
    Health Policy; 2019 Oct; 123(10):963-969. PubMed ID: 31421910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micro-level analysis of distributional changes in health care financing in Finland.
    Klavus J; Häkkinen U
    J Health Serv Res Policy; 1998 Jan; 3(1):23-30. PubMed ID: 10180386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National health expenditures: a global analysis.
    Murray CJ; Govindaraj R; Musgrove P
    Bull World Health Organ; 1994; 72(4):623-37. PubMed ID: 7923542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.
    Brandt J; Shearer B; Morgan SG
    J Pharm Policy Pract; 2018; 11():28. PubMed ID: 30443371
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.